Radiopharmaceuticals in Preclinical and Clinical Development for Monitoring of Therapy with PET

被引:70
作者
Dunphy, Mark P. S. [1 ]
Lewis, Jason S. [1 ]
机构
[1] Mem Sloan Kettering Canc Ctr, Dept Radiol, New York, NY 10065 USA
关键词
PET; therapy monitoring; hypoxia; steroid receptors; proliferation; POSITRON-EMISSION-TOMOGRAPHY; ASSESSING TUMOR HYPOXIA; ADVANCED BREAST-CANCER; AMINO-ACID-TRANSPORT; EVENT-FREE SURVIVAL; PROSTATE-CANCER; IN-VIVO; ESTROGEN-RECEPTOR; BRAIN-TUMORS; C-11-METHIONINE PET;
D O I
10.2967/jnumed.108.057281
中图分类号
R8 [特种医学]; R445 [影像诊断学];
学科分类号
1002 ; 100207 ; 1009 ;
摘要
This review article discusses PET agents, other than F-18-FDG, with the potential to monitor the response to therapy before, during, or after therapeutic intervention. This review deals primarily with non-F-18-FDG PET tracers that are in the final stages of preclinical development or in the early stages of clinical application for monitoring the therapeutic response. Four sections related to the nature of the tracers are included: radiotracers of DNA synthesis, such as the 2 most promising agents, the thymidine analogs 3'-F-18-fluoro-3'-deoxythymidine and F-18-1-(2'-deoxy-2'-fluoro-beta-D-arabinofuranosyl)thymine; agents for PET imaging of hypoxia within tumors, such as Cu-60/62/64-labeled diacetyl-bis(N-4-methylthiosemicarbazone) and F-18-fluoromisonidazole; amino acids for PET imaging, including the most popular such agent, L-[methyl-C-11]methionine; and agents for the imaging of tumor expression of androgen and estrogen receptors, such as 16 beta-F-18-fluoro-5 alpha-dihydrotestosterone and 16 alpha-F-18-fluoro-17 beta-estradiol, respectively.
引用
收藏
页码:106S / 121S
页数:16
相关论文
共 189 条
[1]   Prostate cancer cell cycle regulators: Response to androgen withdrawal and development of androgen independence [J].
Agus, DB ;
Cordon-Cardo, C ;
Fox, W ;
Drobnjak, M ;
Koff, A ;
Golde, DW ;
Scher, HI .
JOURNAL OF THE NATIONAL CANCER INSTITUTE, 1999, 91 (21) :1869-1876
[2]   11C-acetate PET in the early evaluation of prostate cancer recurrence [J].
Albrecht, Susanne ;
Buchegger, Franz ;
Soloviev, Dmitri ;
Zaidi, Habib ;
Vees, Hansjoerg ;
Khan, Haleem G. ;
Keller, Alain ;
Delaloye, Angelika Bischof ;
Ratib, Osman ;
Miralbell, Raymond .
EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2007, 34 (02) :185-196
[3]   Early detection of chemoradioresponse in esophageal carcinoma by 3′-deoxy-3′-3H-fluorothymidine using preclinical tumor models [J].
Apisarnthanarax, Smith ;
Alauddin, Mian M. ;
Mourtada, Firas ;
Ariga, Hisanori ;
Raju, Uma ;
Mawlawi, Osama ;
Han, Dongmei ;
Bornmann, William G. ;
Ajani, Jaffer A. ;
Milas, Luka ;
Gelovani, Juri G. ;
Chao, K. S. Clifford .
CLINICAL CANCER RESEARCH, 2006, 12 (15) :4590-4597
[4]   Using fluorodeoxythymidine to monitor anti-EGFR inhibitor therapy in squamous cell carcinoma xenografts [J].
Atkinson, David M. ;
Clarke, Michelle J. ;
Mladek, Ann C. ;
Carlson, Brett L. ;
Trump, David P. ;
Jacobson, Mark S. ;
Kemp, Brad J. ;
Lowe, Val J. ;
Sarkaria, Jann N. .
HEAD AND NECK-JOURNAL FOR THE SCIENCES AND SPECIALTIES OF THE HEAD AND NECK, 2008, 30 (06) :790-799
[5]   Imaging of cell proliferation: Status and prospects [J].
Bading, James R. ;
Shieds, Anthony F. .
JOURNAL OF NUCLEAR MEDICINE, 2008, 49 :64S-80S
[6]   Pharmacokinetics of the thymidine analog 2′-fluoro-5-methyl-1-β-D-arabinofuranosyluracil (FMAU) in tumor-bearing rats [J].
Bading, JR ;
Shahinian, AH ;
Vail, A ;
Bathija, P ;
Koszalka, GW ;
Koda, RT ;
Alauddin, MM ;
Fissekis, JD ;
Conti, PS .
NUCLEAR MEDICINE AND BIOLOGY, 2004, 31 (04) :407-418
[7]   Imaging hypoxia in tumors [J].
Ballinger, JR .
SEMINARS IN NUCLEAR MEDICINE, 2001, 31 (04) :321-329
[8]  
Barthel H, 2003, CANCER RES, V63, P3791
[9]  
Beer AJ, 2006, J NUCL MED, V47, P763
[10]   Comparison of integrin αvβ3 expression and glucose metabolism in primary and metastatic lesions in cancer patients:: A PET study using 18F-galacto-RGD and 18F-FDG [J].
Beer, Ambros J. ;
Lorenzen, Sylvie ;
Metz, Stephan ;
Herrmann, Ken ;
Watzlowikl, Petra ;
Wester, Hans-Juergen ;
Pesche, Christian ;
Lordick, Florian ;
Schwaiger, Markus .
JOURNAL OF NUCLEAR MEDICINE, 2008, 49 (01) :22-29